DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Information source: Boehringer Ingelheim
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Intervention: Telmisartan (Drug)

Phase: N/A

Status: Completed

Sponsored by: Boehringer Ingelheim

Summary

The aim of the observational study was to supplement the data on efficacy, safety and tolerability of telmisartan under daily conditions in hospitals

Clinical Details

Official title: Observation of Therapy With Micardis« (Telmisartan) in Patients With Essential Hypertension in Hospitals

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome:

Change in clinic blood pressure

Number of patients with adverse drug reactions

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients with diagnosis of essential hypertension

- Minimum age of 18 years

Exclusion Criteria:

- NA

Locations and Contacts

Additional Information

Starting date: May 2000
Last updated: September 11, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017